US Stem Cell Inc (USRM)

[GoldenMind]

USRM has ~X2 revs, ~X3 profits, ~X4 Assets, ~X3.5 Cash in 1 year (from Sept 2016-2017) set up for move to new highs, and brought in $1.5 million in revs & $1 million of gross profit last Q alone

There is so much more going for the company now versus earlier this year when it was trading with a VWAP between $.075-$.14 for 80+ trading days and especially last year or what ever happened almost ten years ago. I am looking forward to more and more revenue growth with overseas expansion with Kuwait and hopefully more trials and updates on RMAT. One big spark and the game changes.

A $15.5 million market cap @ $.0469 could easily be $100mil market cap which would be ~$.30/share. I have seen much much much worse see much higher. A valuation correction is well over due if you ask me and it seems others are beginning to agree. The company knows what it needs to do, they have said time and time again . They doubled revs and tripled profits in 1 year and the stem cell market is growing at an insane rate. Thanks for the cheap shares, especially the last 3 months.


Key growing financials
ASSETS
$283k Jun 2016
$413k Sep 2016
$427k Dec 2016
$1385k Mar 2017
$1632k Jun 2017
$1700k Sept 2017

Revenues
$678k Jun 2016
$729k Sep 2016
$964k Dec 2016
$1154k Mar 2017
$1386k Jun 2017 (Gross profit now $985k vs 443k last Jun 2016)
$1507k Sept 2017 (Gross profit now $1024k vs $397k last Sept 2016)

Cash and Cash Equivalents
$130k Jun 2016
$246k Sep 2016
$270k Dec 2016
$619k Mar 2017
$930k Jun 2017
$957k Sept 2017

2016 Q3 https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11674975
2017 Q1 https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12033381
2017 Q2 https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12218852
2017 Q3 https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12365541

#USRM #STEMCELLS #FDA $USRM